Beijing Ribio Biotech Co., Ltd.

Beijing Ruiboao Biotechnology Co., Ltd. was established in 2007 and is headquartered in Zhongguancun Yongfeng Industrial Base. It is a high-tech company certified by the Beijing Science and Technology Commission that focuses on the research and development, production and sales of ribonucleoside products. After years of development, the company has developed into a comprehensive company integrating research and development, production and sales. The company's production base, Xingtai Ruiboao Biotechnology Co., Ltd., is located in the Renxian Chemical Park, Xingtai City, Hebei Province. The first phase covers an area of 30 acres. The first phase project: an annual output of 5 tons of 2-deoxyribose has been completed and put into trial operation, providing a stable and reliable base for the production of the company's new products. The company's shareholder, Harvest (Hunan) Pharmaceutical Technology Co., Ltd., as the company's R&D headquarters, is located in the High-tech Zone of Yuelu District, Changsha City, Hunan Province. It has a comprehensive laboratory of nearly 1,000 square meters, high-tech equipment assets of nearly 10 million yuan, and nearly 30 talents with master's degrees or above. It focuses on the research and development and approval of new drugs, providing a solid foundation and reliable backing for the company's development in the pharmaceutical field. The company is unique in the field of deoxyribonucleosides. It is currently the first domestic manufacturer of commercial production of bromivudine and trifluridine. 2-deoxyribose has the largest market share at home and abroad. At the same time, the company has successfully developed and produced the advanced intermediates of Sulfondaparinux Sodium, and the research and development of Sofosbuvir has also made breakthrough progress. Talent is the most valuable asset of our company. With the continuous development of the company, a group of professional talents headed by returned overseas doctors have gathered in the field of sugars and nucleosides, which has injected new vitality into the company's research and development and product updates.